News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Accentia Biopharmaceuticals CEO Takes on Second Job as Head of Biovest International, Inc.
March 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dr. Francis O’Donnell Jr. was appointed to serve as chief executive of Biovest International Inc. and will serve without any salary at the struggling biotech firm.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Amgen Makes up to $840M Cancer Play With Dark Blue Takeover
January 7, 2026
·
1 min read
·
Tristan Manalac
Manufacturing
2026: Putting the Reindustrialization Mandate Into Practice
January 6, 2026
·
4 min read
·
Nick Paul Taylor
Weight Loss
Lilly’s Path to $94B in Revenue Rests on Oral Obesity Market and Other 2026 Milestones
January 5, 2026
·
3 min read
·
Annalee Armstrong
Obesity
Novo Unveils Oral Wegovy in the US, With Out-of-Pocket Prices at $149 Per Month
January 5, 2026
·
2 min read
·
Dan Samorodnitsky
